To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05494697
Title Ampligen Compared to No Treatment Following FOLFIRINOX in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors AIM ImmunoTech Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Nebraska Medical Center Omaha Nebraska 68198 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
Virginia Mason Medical Center Seattle Washington 98101 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field